Table 8

Regression results of family member involvement in directorship on audit fees

VariablesModel 10Model 11Model 12
Whole period (2015–2022)Pre-COVID (2015–2018)Post-COVID (2019–2022)
FAMILYDIR−0.0350 (−0.57)−0.0772 (−1.22)−0.0296 (−0.51)
FAMILYDIR*COVID-19−0.0254 (−0.30)  
COVID-190.1334*** (5.91)  
BODMEET0.0190*** (10.46)0.0217*** (8.40)0.0166*** (6.47)
BODSIZE0.0473*** (5.26)0.0367** (3.00)0.0613*** (4.62)
IDR0.0069*** (3.31)0.0062* (2.19)0.0086** (2.80)
INVESTPROP0.0035*** (16.39)0.0038*** (12.39)0.0033*** (10.96)
LEV0.9217*** (28.75)0.8725*** (18.50)0.9518*** (21.77)
ROE0.4516*** (4.55)0.8577*** (5.76)0.1250 (0.94)
INVR−0.1393*** (−4.27)−0.1024* (−2.22)−0.1638*** (−3.55)
FIRMAGE0.0031** (2.85)−0.0001 (−0.08)0.0058*** (3.84)
BIG40.4799*** (16.45)0.4712*** (9.58)0.4879*** (13.52)
_cons12.3860*** (83.19)12.5194*** (61.69)12.3289*** (56.60)
N6,2193,0393,180
adj. R20.28680.26760.2844
F209.3360111.9995127.3736

Note(s): FAMILYDIR = family members on board of directors, COVID-19 = COVID-19 pandemic, BODMEET = board meetings, BODSIZE = directors on the board, IDR = independent directors on the board, INVESTPROP = institutional investor shareholder ratio, LEV = total liability/total assets, ROE = return on equity, INVR = inventory/total revenue, FIRMAGE = firm living years, and BIG4 = Big 4; *p < 0.1, **p < 0.05, ***p < 0.01 (t statistics in parentheses)

Source(s): Authors’ own creation

or Create an Account

Close Modal
Close Modal